Company / Revenue per Share
Co-Diagnostics, Inc. Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.56
FY2025
5-year range
$0.13 / $2.89
FY2021-FY2025
Trend
+351.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share changed +351% YoY in FY2025, a notable deviation from the 8-year average annual change of +2733%.
Based on SEC 10-K filings.
0.56 in FY2025 with a 5-year CAGR of +114.7%.
Improved from $0.22 to $0.56 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -42.0%
- 5-Year CAGR
- +114.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 351.1% year-over-year.
- Peak revenue per share was recorded in FY2022.
- Lowest revenue per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.56 | +351.1% |
| FY2024 | $0.13 | -43.2% |
| FY2023 | $0.22 | -92.4% |
| FY2022 | $2.89 | +10.9% |
| FY2021 | $2.61 | +20960.6% |
| FY2020 | $0.01 | +301.4% |
| FY2019 | $0.00 | +396.5% |
| FY2018 | $0.00 | -19.8% |
| FY2017 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026